tiprankstipranks
Advertisement

XMAG - ETF AI Analysis

Compare

Top Page

XMAG

Defiance Large Cap ex-Mag 7 ETF (XMAG)

Rating:72Outperform
Price Target:
XMAG, the Defiance Large Cap ex-Mag 7 ETF, earns a solid overall rating thanks to high-quality blue-chip holdings like Johnson & Johnson and Walmart, which show strong financial performance, positive earnings calls, and supportive corporate events that point to durable growth. Other major positions such as Broadcom, Exxon Mobil, and JPMorgan also add strength through robust cash generation and strategic initiatives, though some names like Berkshire Hathaway, Visa, and Costco face bearish technical trends or rich valuations, which slightly weigh on the fund. The main risk factor is that several key holdings are priced for growth or show weaker technical momentum, which could increase volatility if market sentiment turns.
Positive Factors
Well-Known Large-Cap Holdings
The ETF holds many established blue-chip companies, which can provide stability and recognizable brand strength in the portfolio.
Broad Sector Diversification
Exposure across many sectors, including technology, financials, health care, and consumer stocks, helps reduce the impact if any one industry struggles.
Recent Positive Performance
The fund has shown steady gains over the past month, three months, and year-to-date, indicating improving recent momentum.
Negative Factors
Several Weak Top Holdings
A number of the largest positions, such as major financial and payment companies, have shown weak performance so far this year, which can drag on returns.
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification.
Moderate Expense Ratio
The fund’s fee is not especially low, which means a noticeable portion of returns will go toward covering expenses each year.

XMAG vs. SPDR S&P 500 ETF (SPY)

XMAG Summary

XMAG is an ETF that tracks the BITA US 500 ex-Magnificent 7 Index, meaning it invests in large U.S. companies but leaves out the seven biggest tech giants. It holds well-known names like JPMorgan Chase, Berkshire Hathaway, Exxon Mobil, Walmart, and Costco, spread across sectors such as technology, health care, financials, and consumer goods. Someone might invest in XMAG to get broad stock market exposure without being overly tied to the largest tech stocks, which can dominate many funds. A key risk is that it can still rise or fall with the overall stock market, and it may lag funds that include the “Mag 7” if those stocks outperform.
How much will it cost me?The expense ratio for the Defiance Large Cap ex-Mag 7 ETF (XMAG) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to exclude the 'Mag 7' tech giants, requiring more oversight and strategy. It’s designed for investors seeking a unique approach to large-cap stocks.
What would affect this ETF?XMAG's focus on excluding the 'Mag 7' tech giants could benefit from a shift in investor sentiment towards diversification and reduced reliance on mega-cap tech stocks. Positive drivers include potential growth in sectors like financials and healthcare, which are significant holdings, and stability from its broad exposure to U.S. large-cap companies. However, negative factors such as rising interest rates could pressure financial stocks, and economic slowdowns might impact consumer-focused sectors like Consumer Defensive and Consumer Cyclical.

XMAG Top 10 Holdings

XMAG leans heavily into U.S. large caps beyond the usual tech titans, with a noticeable tilt toward technology, financials, and health care. Micron and Exxon Mobil are the current engines, rising on AI chip optimism and firm energy profits. Johnson & Johnson, Costco, and Walmart are providing steadier, more defensive ballast, helping smooth the ride. On the flip side, Broadcom and Visa have been losing altitude lately, and Eli Lilly’s recent slide means some of the fund’s biggest non-tech growth hopes are catching their breath rather than pulling the ETF higher.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Broadcom4.09%$5.43M$1.68T105.98%
76
Outperform
JPMorgan Chase2.07%$2.75M$836.97B36.64%
72
Outperform
Eli Lilly & Co2.03%$2.70M$902.48B32.50%
72
Outperform
Berkshire Hathaway B1.66%$2.21M$1.05T-5.93%
66
Neutral
Exxon Mobil1.63%$2.16M$646.02B55.15%
74
Outperform
Johnson & Johnson1.46%$1.93M$581.22B62.29%
78
Outperform
Walmart1.39%$1.85M$1.03T42.51%
78
Outperform
Visa1.30%$1.73M$587.60B-5.03%
70
Outperform
Costco1.15%$1.52M$457.86B7.02%
72
Outperform
Micron1.15%$1.52M$475.35B501.73%
79
Outperform

XMAG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
22.81
Positive
100DMA
22.67
Positive
200DMA
22.16
Positive
Market Momentum
MACD
-0.01
Negative
RSI
62.08
Neutral
STOCH
93.99
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XMAG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 22.36, equal to the 50-day MA of 22.81, and equal to the 200-day MA of 22.16, indicating a bullish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 62.08 is Neutral, neither overbought nor oversold. The STOCH value of 93.99 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XMAG.

XMAG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$132.66M0.35%
72
Outperform
$990.08M0.05%
74
Outperform
$948.09M0.05%
74
Outperform
$926.67M0.10%
75
Outperform
$866.83M0.15%
68
Neutral
$853.58M0.35%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XMAG
Defiance Large Cap ex-Mag 7 ETF
23.12
4.86
26.62%
STRV
Strive 500 ETF
VOTE
Engine No. 1 Transform 500 ETF
EFIV
SPDR S&P 500 ESG ETF
QQQJ
Invesco NASDAQ Next Gen 100 ETF
BALI
BlackRock Advantage Large Cap Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement